For adults with T2D at high risk of major CV events Ozempic (semaglutide) pill: proven CV risk reduction 6 (semaglutide) pill: proven CV risk reduction 6 Start Ozempic pill today in adults with T2D who are at high risk for major CV events Ozempic pill can significantly lower the risk of MACE 6,7 pill can significantly lower the risk of MACE 6,7 Primary composite endpoint: Reduction in risk of MACE with semaglutide tablets 14 mg vs placebo when both were added to SOC in adults with T2D and established CVD and/or CKD 6 Time to first confirmed MACE (CV death, nonfatal MI, or nonfatal stroke) 6,7,b NNT 50 Number needed to treat to prevent d 1 MACE (3 years) 7,d Ozempic tablets 1.5 mg, 4 mg, and 9 mg are an updated formulation with increased bioavailability
Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men
The control group (CON group
Volarevic V, Markovic BS, Gazdic M, et al
Inflammation and immune homeostasis The carnitine pool plays a role in the maintenance of inflammation and immune homeostasis